Strikingly, over 60% of the ETP-ALL cases exhibited a mutation in one of these three genes: FLT3, DNMT3A, NOTCH1, again reflecting the lymphoid-myeloid potential of the disease (Fig. 2) [6]. Here, DNMT3A is linked to acute lymphoblastic leukemia.